Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

A process for equine influenza virus vaccine production using a microcarrier system (Cytodex 1) in a 2 L Wave bioreactor is described. Growth of Madin Darby canine kidney (MDCK) cells in serum containing GMEM medium (SC) is compared to growth in serum-free Ex-Cell MDCK medium (SF) without washing steps and medium exchange before infection. Cultivations with microcarrier concentrations of 2 and 4 g/L for both media are shown. Metabolic data from carbon and amino acid metabolism are discussed. Additionally, in roller bottle experiments the influence of multiplicity of infection (moi) and trypsin concentration on the HA value was investigated. Analysis of HA and TCID(50) at 37 degrees C showed a stable HA of maximum 2.6 log HA/100 microL for 2 weeks. Peak TCID(50) titers of 10(7.7) viruses/mL were achieved 20h post infection, but infectivity was below detection limit after 150 h. Cell attachment onto microcarriers under serum-free conditions was improved by Ca(2+) addition and by cell harvesting without trypsin using only an EDTA/PBS solution. For the wave cultivation maximum virus titers of 2.3-2.6 log HA units/100 microL were reached from infection with a moi of 0.05. However, in SF medium pH dropped to less than pH 6.8 which resulted in lower HA titers of 1.7 log HA units/100 microL. For the higher microcarrier concentration (4 g/L) medium exchange steps (500 mL) were needed for both media. Omission of the washing step and medium exchange before infection in SF medium clearly simplified the influenza production process; however, for higher virus yields a better pH control of the wave bioreactor would be required. Higher cell densities (2.8 x 10(6) cells/mL for 2 g/L microcarrier) and better attachment compared to stirred tank bioreactors showed, that the wave bioreactor is a good alternative to stirred tank processes for expanding production capacities in case of a pandemic.

[1]  Hong Yu,et al.  Simultaneous determination of amino acids and carbohydrates by anion-exchange chromatography with integrated pulsed amperometric detection. , 2002, Journal of chromatography. A.

[2]  J. Ljunggren,et al.  Physiology of cultured animal cells. , 1997, Journal of biotechnology.

[3]  A. Fooks,et al.  Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. , 2001, Vaccine.

[4]  J. P. van Dijken,et al.  Fluxes and enzyme activities in central metabolism of myeloma cells grown in chemostat culture. , 1998, Biotechnology and bioengineering.

[5]  Regine Eibl,et al.  Growth and Ginsenoside Production in Hairy Root Cultures of Panax ginseng using a Novel Bioreactor , 2003, Planta medica.

[6]  Y. Schneider,et al.  Fortification of a protein-free cell culture medium with plant peptones improves cultivation and productivity of an interferon-γ-producing CHO cell line , 2003, In Vitro Cellular & Developmental Biology - Animal.

[7]  Vijay P. Singh,et al.  Disposable bioreactor for cell culture using wave-induced agitation , 1999, Cytotechnology.

[8]  Sabine Geisse,et al.  Optimisation of protein expression and establishment of the Wave Bioreactor for Baculovirus/insect cell culture , 2004, Cytotechnology.

[9]  R. Bhatia,et al.  Growing Cholesterol‐Dependent NS0 Myeloma Cell Line in the Wave Bioreactor System: Overcoming Cholesterol‐Polymer Interaction by Using Pretreated Polymer or Inert Fluorinated Ethylene Propylene , 2005, Biotechnology progress.

[10]  C. Korzeniewski,et al.  An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.

[11]  A. Osterhaus,et al.  Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. , 1999, Vaccine.

[12]  Udo Reichl,et al.  Substitution of Glutamine by Pyruvate To Reduce Ammonia Formation and Growth Inhibition of Mammalian Cells , 2008, Biotechnology progress.

[13]  B. Mahy,et al.  Virology methods manual , 1996 .

[14]  U. Reichl,et al.  Monitoring of Cell Physiology in Influenza Vaccine Production by Flow Cytometry , 2007 .

[15]  U von Stockar,et al.  Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production. , 1996, Journal of Biotechnology.

[16]  U. Reichl,et al.  Downstream processing of MDCK cell-derived equine influenza virus. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  J. Auniņš,et al.  Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector. , 2005, Biotechnology and bioengineering.

[18]  J. Manuguerra,et al.  Production of influenza virus in cell cultures for vaccine preparation. , 1996, Advances in experimental medicine and biology.

[19]  Udo Reichl,et al.  Amino acid analysis in mammalian cell culture media containing serum and high glucose concentrations by anion exchange chromatography and integrated pulsed amperometric detection. , 2004, Analytical biochemistry.

[20]  Animal Cell Culture, Physiochemical Effects of pH , 2003 .

[21]  A. Osterhaus,et al.  Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. , 1998, Journal of virological methods.

[22]  G. Tannock,et al.  The growth of attenuated influenza vaccine donor strains in continuous cell lines. , 2005, Journal of virological methods.

[23]  U. Reichl,et al.  Glutamine-free media for vaccine production processes , 2005 .

[24]  Merten Ow.  Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media. , 2002 .

[25]  M. Aymard,et al.  Suitability of MDCK cells grown in a serum-free medium for influenza virus production. , 1999, Developments in biological standardization.

[26]  J. Manuguerra,et al.  Production of influenza virus in serum-free mammalian cell cultures. , 1999, Developments in biological standardization.

[27]  P. Friedl,et al.  Serum- and protein-free media formulations for the Chinese hamster ovary cell line DUKXB11. , 2004, Journal of biotechnology.

[28]  H. Kallel,et al.  Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. , 2006, Journal of biotechnology.

[29]  M. Carrondo,et al.  Virus‐like particle production at low multiplicities of infection with the baculovirus insect cell system , 2003, Biotechnology and bioengineering.

[30]  U. Bjare.  Serum-free cell culture. , 1992, Pharmacology & therapeutics.

[31]  A. Palache,et al.  Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. , 1999, Developments in biological standardization.

[32]  U Reichl,et al.  Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. , 2006, Vaccine.

[33]  I. Marison,et al.  The importance of ammonia in mammalian cell culture. , 1996, Journal of biotechnology.

[34]  R. Spier,et al.  Genetic engineering of hybridoma glutamine metabolism. , 1995, Enzyme and microbial technology.

[35]  Raymond E. Spier.,et al.  Encyclopedia of cell technology , 2000 .

[36]  U Reichl,et al.  Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. , 2004, Vaccine.